BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6516292)

  • 1. A single-step method for the isolation of antithrombin III.
    Wickerhauser M; Williams C
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
    Wickerhauser M; Williams C; Mercer J
    Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pasteurized antithrombin III concentrate for clinical use.
    Smith JK; Winkelman L; Evans DR; Haddon ME; Sims G
    Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and large-scale preparation of antithrombin III.
    Hoffman DL
    Am J Med; 1989 Sep; 87(3B):23S-26S. PubMed ID: 2801726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y; Shizuka R; Oshitani S; Amagai H
    Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
    Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH; Tamachi H; Homma Y; Goto Y
    Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
    Lebing WR; Hammond DJ; Wydick JE; Baumbach GA
    Vox Sang; 1994; 67(2):117-24. PubMed ID: 7801599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of two distinct types of antithrombin III from rabbit.
    Carlson TH; Atencio AC
    Thromb Res; 1982 Jul; 27(1):23-34. PubMed ID: 7123512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
    Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
    Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
    D'Souza S; Ananthakrishnan R
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.